R
Rezolute, Inc.
RZLT · NASDAQ · Healthcare · 443M
Price · close
$5.09
+9.23% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.4×
Enterprise value / EBITDAEV/EBITDA
-4.0×
Free cash flow yieldFCF yield
-17.9%
Return on equityROE
-45.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.